Zydus Cadila Opens New Fronts In COVID-19 Battle
US Injectables And Transdermals Business Ramp-Up Contingent on Moraiya Remediation
With seven COVID-19 treatment/prophylactic candidates lined up, India's Zydus Cadila is unleashing all it can to combat the disease. Meanwhile, the firm has also offered an update on the state of its injectables and transdermals business in the US, which is contingent on resolving deficiencies at its Moraiya plant.
